Indeed, the inhibitors used show equivalent or greater activity on a number of other protein kinases including PKCs, RSK and S6 kinase, with known roles in cardiac hypertrophy [9,39,41]. The gene discussed is RPS6KA3; the disease is cardiac hypertrophy.